We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
Results for
"[search-keyword]"
Sponsor content
3 result(s) found, displaying 1 to 3
-
Australian Public Assessment Report (AusPAR)Kalydeco (ivacaftor) was approved to treat cystic fibrosis in patients aged 4 months and older who have at least one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Elexacaftor/tezacaftor/ivacaftor and ivacaftor
-